STING1 and breast carcinoma: Here, we employed a metastatic breast cancer mouse model using the EO771 cell line [18,19] that carries a high mutation burden [20] to investigate the role of host cGAS, STING, and the IFN-I response in the anti-tumor effect of CTX.